Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014 | Zendy

Catherine S. Hwang | Zendy; Elizabeth M. Kang | Zendy; Yulan Ding | Zendy; Josephine OcranAppiah | Zendy; Jana McAninch | Zendy; Judy A. Staffa | Zendy; Cynthia Kornegay | Zendy; Tamra E. Meyer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014

Author(s) -

Catherine S. Hwang,

Elizabeth M. Kang,

Yulan Ding,

Josephine OcranAppiah,

Jana McAninch,

Judy A. Staffa,

Cynthia Kornegay,

Tamra E. Meyer

Publication year - 2018

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2018.0216

Subject(s) - analgesic , opioid , chronic pain , pain management , anesthesia , medicine , psychiatry , receptor

Key Points Question What percentage of patients receiving long-term immediate-release (IR) opioid analgesic therapy in the United States adds or switches to an extended-release/long-acting (ER/LA) formulation? Findings In this cohort study, most patients (96.0%) receiving IR formulations for 90 days or longer continued IR opioid analgesic use without adding (3.3%) or switching (0.7%) to an ER/LA product. Furthermore, many patients received only 1 IR (40%) and/or 1 ER/LA (41%) prescription throughout the 12-year study period. Meaning Most patients receiving opioid analgesics use IR formulations, and patients receiving long-term IR opioid analgesic therapy are unlikely to add or switch to an ER/LA formulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research